Colorado Health Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Colorado Health Reporter.

Press releases published on June 1, 2026

Jun. 1, 2026

NextCure Presents Positive SIM0505 Phase 1 Dose Escalation Data in Patients with Gynecologic Cancers at ASCO 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

Cytokinetics Launches MYQORZO® (aficamten) in European Union, with First Commercial Availability in Germany

Indeterminate GlobeNewswire

Jun. 1, 2026

Helus Pharma to Participate in the Jefferies Global Healthcare Conference in New York

Indeterminate GlobeNewswire

Jun. 1, 2026

Immuneering Presents Compelling 17.3-Month Median Overall Survival and Favorable Tolerability with Atebimetinib + Chemotherapy in First-Line Pancreatic Cancer Patients at ASCO

Indeterminate GlobeNewswire

Jun. 1, 2026

TG Therapeutics Announces Publication of Post-Hoc Data from the Phase 3 ULTIMATE I & II Trials in Treatment Naive Patients with Relapsing Forms of MS Published in Frontiers in Immunology

Indeterminate GlobeNewswire

Jun. 1, 2026

BriaCell Presents Positive Clinical Data at ASCO 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

Option Care Health Awarded TIME's World's Most Impactful Companies 2026 Ranking

Indeterminate GlobeNewswire

Jun. 1, 2026

Jade Biosciences Announces Positive Interim Phase 1 Results for JADE101 Demonstrating Potential Best-in-Class Profile and Every-12-Week Dosing in IgA Nephropathy

Indeterminate GlobeNewswire

Jun. 1, 2026

Axsome Therapeutics Partners with the Headache Alliance to Highlight the Impact of Migraine During Migraine and Headache Awareness Month

Indeterminate GlobeNewswire

Jun. 1, 2026

Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory

Indeterminate GlobeNewswire

Jun. 1, 2026

Life Sciences Investment Opportunities Accelerate as AI and Genomics Drive $200+ Billion Market Expansion

Indeterminate GlobeNewswire

Jun. 1, 2026

Human Appeal Releases “Thrive with Dignity” Impact Report, Highlighting Support for Over 7.3 Million People Globally

Indeterminate GlobeNewswire

Jun. 1, 2026

Rejuvenate Biomed Completes Recruitment in Phase 2 Trial Assessing First-in-Class Multi-Pathway Therapeutic RJx-01 in COPD-Induced Sarcopenia

Indeterminate GlobeNewswire

Jun. 1, 2026

Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study

Indeterminate GlobeNewswire

Jun. 1, 2026

Greenwich LifeSciences Provides Update Regarding Form 10-K Filing

Indeterminate GlobeNewswire

Jun. 1, 2026

ITM Announces Phase 3 COMPETE Data Supporting Single-Timepoint Dosimetry for n.c.a. ¹⁷⁷Lu-edotreotide (ITM-11) in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at SNMMI 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

Intravacc and Primrose Bio Renew Partnership to Enhance Conjugate Vaccine Development

Indeterminate GlobeNewswire

Jun. 1, 2026

Avacta presents updated clinical data showing encouraging early efficacy signals for AVA6000 in salivary gland cancers at ASCO 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus

Indeterminate GlobeNewswire